Cargando…
Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPK
Obesity is an epidemic affecting 13% of the global population and increasing the risk of many chronic diseases. However, only several drugs are licensed for pharmacological intervention for the treatment of obesity. As a master regulator of metabolism, the therapeutic potential of AMPK is widely rec...
Autores principales: | Bao, Ruoxuan, Meng, Yongmei, Zhang, Haibo, Yang, Chen, Li, Wei, Zhang, Cheng, Zhang, Jinye, Sun, Renqiang, Li, Zengxia, Jiang, Wei, Zhang, Chensong, Zhang, Changsheng, Yuan, Hai-Xin, Dang, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528873/ https://www.ncbi.nlm.nih.gov/pubmed/34671010 http://dx.doi.org/10.1038/s41419-021-04264-9 |
Ejemplares similares
-
Natural Occurrence, Bioactivity and Biosynthesis of Elaiophylin Analogues
por: Gui, Min, et al.
Publicado: (2019) -
Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis
por: Lim, Haet Nim, et al.
Publicado: (2018) -
Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
por: Zheng, Jianwei, et al.
Publicado: (2020) -
Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation
por: Li, Guan-Nan, et al.
Publicado: (2022) -
Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic Cancer Cells
por: Huang, Lufen, et al.
Publicado: (2023)